Desq Long
Sign in

Company

TAKEDA PHARMACEUTICAL CO LTD

TAK · CIK 0001395064

SEC FORM 4
$640,278.90

TAKEDA PHARMACEUTICAL CO LTD (TAK)

Sale of 34,535 shares at $18.54 per share.

Reporting Person Duprey Lauren Rusckowski · Officer Title Chief Transformation Officer · Transaction Code S

Traded Sep 14, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001395064-26-000340 · filed 2026-09-15 · View filing →

SEC FORM 4
$2,148,371.59

TAKEDA PHARMACEUTICAL CO LTD (TAK)

Sale of 116,191 shares at $18.49 per share.

Reporting Person Plump Andrew Stewart · Officer Title President, R&D · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001395064-26-000335 · filed 2026-09-03 · View filing →

SEC FORM 4
$363,346.99

TAKEDA PHARMACEUTICAL CO LTD (TAK)

Sale of 19,651 shares at $18.49 per share.

Reporting Person Plump Andrew Stewart · Officer Title President, R&D · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001493152-26-039693 · filed 2026-08-21 · View filing →

SEC FORM 4
$235,118.42

TAKEDA PHARMACEUTICAL CO LTD (TAK)

Sale of 12,980 shares at $18.1139 per share.

Reporting Person Greenway Nicola Deidre Petal · Officer Title Chief Human Resources Officer · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001493152-26-039214 · filed 2026-08-19 · View filing →

SEC FORM 4
$357,370.65

TAKEDA PHARMACEUTICAL CO LTD (TAK)

Sale of 20,363 shares at $17.55 per share.

Reporting Person Shannon Elaine Mary · Officer Title Pres., Global Supply & Quality · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001493152-26-037352 · filed 2026-08-12 · View filing →

SEC FORM 4
$17,062.50

TAKEDA PHARMACEUTICAL CO LTD (TAK)

Sale of 975 shares at $17.50 per share.

Reporting Person Greenway Nicola Deidre Petal · Officer Title Chief Human Resources Officer · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001493152-26-037351 · filed 2026-08-12 · View filing →

SEC FORM 4
$588,715.31

TAKEDA PHARMACEUTICAL CO LTD (TAK)

Sale of 33,628 shares at $17.5067 per share.

Reporting Person Greenway Nicola Deidre Petal · Officer Title Chief Human Resources Officer · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001493152-26-037351 · filed 2026-08-12 · View filing →

SEC FORM 4
$527,842.80

TAKEDA PHARMACEUTICAL CO LTD (TAK)

Sale of 30,868 shares at $17.10 per share.

Reporting Person Furney Natalie Anne Marie · Officer Title Global General Counsel · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001493152-26-037480 · filed 2026-08-12 · View filing →

SEC FORM 4
$531,519.30

TAKEDA PHARMACEUTICAL CO LTD (TAK)

Sale of 31,083 shares at $17.10 per share.

Reporting Person Platford Giles Richard · Officer Title President, IBU · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001493152-26-037482 · filed 2026-08-12 · View filing →

SEC FORM 4
$1,523,439.00

TAKEDA PHARMACEUTICAL CO LTD (TAK)

Sale of 89,090 shares at $17.10 per share.

Reporting Person Kim Julie So-Young · Officer Title President and CEO · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001493152-26-037484 · filed 2026-08-12 · View filing →

SEC FORM 4
$115,835.40

TAKEDA PHARMACEUTICAL CO LTD (TAK)

Sale of 6,774 shares at $17.10 per share.

Reporting Person Greenway Nicola Deidre Petal · Officer Title Chief Human Resources Officer · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001493152-26-037486 · filed 2026-08-12 · View filing →

SEC FORM 4
$429,004.80

TAKEDA PHARMACEUTICAL CO LTD (TAK)

Sale of 25,088 shares at $17.10 per share.

Reporting Person Ricci Gabriele · Officer Title Chief Data & Tech. Officer · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001493152-26-037494 · filed 2026-08-12 · View filing →

SEC FORM 4
$68,023.80

TAKEDA PHARMACEUTICAL CO LTD (TAK)

Sale of 3,978 shares at $17.10 per share.

Reporting Person Shannon Elaine Mary · Officer Title Pres., Global Supply & Quality · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001493152-26-037499 · filed 2026-08-12 · View filing →

SEC FORM 4
$855,205.20

TAKEDA PHARMACEUTICAL CO LTD (TAK)

Sale of 50,012 shares at $17.10 per share.

Reporting Person Bitetti Teresa Marie · Officer Title President, OBU · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001493152-26-037502 · filed 2026-08-12 · View filing →

SEC FORM 4
$392,564.70

TAKEDA PHARMACEUTICAL CO LTD (TAK)

Sale of 22,957 shares at $17.10 per share.

Reporting Person Pignagnoli Agosti Marcello · Officer Title Head, Strat. & Port. Dev · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001493152-26-037505 · filed 2026-08-12 · View filing →

SEC FORM 4
$2,828,220.30

TAKEDA PHARMACEUTICAL CO LTD (TAK)

Sale of 165,393 shares at $17.10 per share.

Reporting Person Plump Andrew Stewart · Officer Title President, R&D · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001493152-26-037507 · filed 2026-08-12 · View filing →

SEC FORM 4
$813,720.60

TAKEDA PHARMACEUTICAL CO LTD (TAK)

Sale of 47,586 shares at $17.10 per share.

Reporting Person Duprey Lauren Rusckowski · Officer Title Chief Transformation Officer · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001493152-26-037509 · filed 2026-08-12 · View filing →

SEC FORM 4
$289,007.10

TAKEDA PHARMACEUTICAL CO LTD (TAK)

Sale of 16,901 shares at $17.10 per share.

Reporting Person Pacheco Rhonda Janice · Officer Title President, U.S. Business Unit · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001493152-26-037513 · filed 2026-08-12 · View filing →

SEC FORM 4
$124,436.70

TAKEDA PHARMACEUTICAL CO LTD (TAK)

Sale of 7,277 shares at $17.10 per share.

Reporting Person Ibrahim Ramy Riad Ahmed · Officer Title President, PDT BU · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001493152-26-037514 · filed 2026-08-12 · View filing →

SEC FORM 4
$239,502.60

TAKEDA PHARMACEUTICAL CO LTD (TAK)

Sale of 14,006 shares at $17.10 per share.

Reporting Person Farajallah Awny Samaan Botros · Officer Title Chief Medical Officer · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001493152-26-037515 · filed 2026-08-12 · View filing →